Dr Teh Ming Ming

About

• Set up the multidisciplinary inpatient diabetes service in SGH which has been shown to improve glycemic control and reduce the length of stay. 
• Service chief on the SGH campus to promote inpatient diabetes care.
• Team leader for Singapore Healthcare improvement Network Large Scale Initiative (SHINe LSI )in improving safety of nil by mouth diabetes patients
• Current research programme focuses on impairment of hypoglycaemia awareness in type 2 diabetes , hypoglycaemia in the elderly type 2 diabetes and  strategies in improving inpatient diabetes care.
• Completed MD postgraduate degree in Kings’ College London, using positron emission topography neuroimaging technique to research into the phenomenon of impaired hypoglycaemia awareness in type 1 diabetes patients, under the supervision of Professor Stephanie Amiel.
• Was a consultant endocrinologist in the Heart of England NHS Foundation Trust (HEFT) in the United Kingdom prior to joining SGH in 2014.   While working in HEFT, Dr Teh 
• set up the first islet transplant service in the Midlands . Dr Teh was also  
• the Committee Member of the Clinical Reference Group for Specialised Diabetes in  West Midlands ,Medical advisor to the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Medical assessor for the Driving and Vehicle Licensing Agency (DVLA). 
  

Education and Training

• MD (University of London)-2007
• MRCP (UK)-2002
• MB BCh BAO (University College Dublin)-1997

Professional Appointments and Committee Memberships

• Clinical Performance Improvement Committee
• Medical Safety Committee 
• Service Chief SGH campus
• Team Leader for the Singapore Healthcare Improvement Network Large Scale Initiative (SHINE LSI)
• Clinical Evaluation Committee Member for MOHH Sponsored Initiative on Vital Sign Monitoring Platform
• Clinical Physician Faculty Member for Residency Programme
• Endocrine Representative for Health IT Initiatives by Ministry of Health

Awards

• ​Silver Award for Singapore Health Quality Service Awards

Research Interests

• ​Hypoglycaemia
• Inpatient diabetes
• Diabetes

Publications

1. DS Swee, LC Ang, WM Heng, D Lee, X Xin, SS Kumaran, KS Wong, YM Bee, SY Goh, MM Teh. Inpatient Glucose Management Programme In the Asian Healthcare Setting.  Accepted by International Journal of Clinical Practice.
2. L Zhu, LC Ang, WB Tan, X Xin, YM Bee, SY Goh , MM Teh. A study to evaluate the prevalence of impaired awareness of hypoglycaemia in adults with type 2 diabetes in outpatient clinic in a tertiary care centre in Singapore. Ther Adv Endocrinol Metab. 2017 May;8(5):69-74
3. A Brown, A Gouldstone, J shakher, S Bellary, MM Teh, M Azzam, R John, A Jagielske, T Arora, G Thomas, S Taheri.  Description and Preliminary Results from a structured specialist behavioural weight management group intervention: Specialist Lifestyle Management (SLiM) programme. BMJ Open 2015 Apr 8;5(4):e007217.doi:10.1136/bmjopen-2014-007217 
4. B Jose, M Colloby, U Griffiths, S Nyika, MM Teh.  Inpatient Audit of Hypoglycaemia in Older People with Type 2 Diabetes. Journal of Diabetes Nursing, 2011: 15(9);343-347
5. MM Teh, JT Dunn, P Choudhary, Y Samarasinghe, I MacDonald, M O’Doherty, PK Marsden, LJ Reed, SA Amiel. Evolution and Resolution of Human Brain Responses to Prolonged Interoceptive Stress: A PET Perfusion Study in Hypoglycaemia.  Neuroimage, 2010:53(2), 584-592.
6. MSB Huda, NB Athauda, MM Teh, PV Carroll and JK Powrie.  Factors determining the remission of microprolactinomas after dopamine agonist withdrawal. Clinical Endocrinology, 2010, 72(4):507-11. 
7. MM Teh, AP Brooks, JSW Li Voon Chong. Metabolic Targets Achieved in Elderly Diabetic Patients Attending A Secondary Care Annual Review Diabetic Clinic. Diabetic Medicine, 2004:21(9), 1052-1053.
8. MM Teh, MJS Zaman, AP Brooks, JSW Li Voon Chong. When is high potassium not high potassium? Journal of Royal Society of Medicine, 2003:96, 354-355
9. ME Griffin, K Nikookam, MM Teh, H McCann, NM O’Meara, RG Firth.  Dobutamine Stress Echocardiography.  False Positive Scans in proteinuric patients with Type I Diabetes Mellitus at High Risk of Ischaemic Heart Disease. Diabetic Medicine, 1998: 15(5), 427-430.